Category: Blog

Telemedicine Future

How Telemedicine Play a Major Role In The Future Of Healthcare?

Telemedicine is proving to be of great value to patients as well as the health professionals. The most significant innovation of telemedicine over in-person visits is the opportunity for better patient follow up and increased health outcomes. Traditionally, the hospitals recommended a treatment plan or prescribed medications, then hoped the patient followed their advice. But […]
Unexpected Medical Bills

Congress Takes Steps to Curb Unexpected Medical Bills

Most Americans tell pollsters they’re worried about being able to afford an unexpected medical bill. Late Monday, Congress passed a bill to allay some of those fears. The measure is included in a nearly 5,600-page package providing coronavirus economic relief and government funding for the rest of the fiscal year. Specifically, the legislation addresses those […]
hospital price transparency rule

CMS to Audit Some Hospitals for Price Transparency Compliance

CMS is taking steps to ensure hospitals comply with a controversial price transparency rule taking effect on January 1, 2021. On that date, every hospital in the country is expected to provide publicly accessible standard charge information about the items and services they render. That includes gross charges, discounted cash prices, de-identified minimum and maximum negotiated […]
Health System for COVID-19 Vaccine Distribution

4 Ways Health Systems are Approaching COVID-19 Vaccine Distribution

As hospitals and health systems continue the battle against COVID-19, shipments of vaccine are arriving to protect the highest-risk employees. As more doses become available in the weeks ahead, initiatives will ramp up in an effort to deploy the vaccine to millions of Americans. HealthLeaders has been talking to health system representatives about their deployment […]
AstraZeneca COVID-19 Vaccine

AMA Creates CPT Codes for AstraZeneca’s COVID-19 Vaccine

In anticipation of an emergency use authorization from the Food and Drug Administration (FDA), the American Medical Association (AMA) has created Current Procedural Terminology (CPT) codes for AstraZeneca’s COVID-19 vaccine. AMA assigned Category 1 CPT code 91302 to the vaccine manufactured by the Cambridge, United Kingdom (UK) company, as well as vaccine administration CPT codes […]
Surprise Billing Regulation

Congress Provides Relief on Medicare Payment; Passes Surprise Billing

  The $1.4 trillion omnibus legislative package passed by Congress late Monday includes COVID-19 related relief for physicians, imposes new restrictions on surprise billing, and funds the government through fiscal 2021, which ends Sept. 30. The legislation mitigates budget neutrality cuts that would have slashed physician Medicare payment rates by 10.2% and extends the moratorium on the […]
AR VR in Healthcare Future

Role of AR/VR in The Future of Care

With a VR headset, live joint images can be recorded, filmed, and recorded continuously as the patient moves, monitoring the motion range. Since points are taken in 3-D space, the incorporation of live imagery and measurement provides more precision, accuracy, and freedom of movement since there are no device constraints. Virtual Reality (VR) and Augmented […]
Telehealth Future

What Does The Future of Telehealth LookLike?

The telehealth industry saw demand surge significantly this spring as Covid-19 began. Telehealth appointments are ideal for a pandemic: patients can seek an informed opinion about their symptoms and be referred for a medical test without having to go to the office physically and placing people at risk. But while the focus on telehealth has […]
COVID-19 Part-B Payment

CMS Updates Part B Payment Information For Covid-19 Treatments

A version of this article was first published December 16, 2020, by HCPro’s Revenue Cycle Advisor, a sibling publication to HealthLeaders. CMS released new and updated FAQs on Medicare Part B billing and reimbursement for COVID-19 treatments and vaccines. The information updated December 9 is included in Section BB, Drugs and Vaccines under Part B of CMS’ COVID-19 […]